Logotype for Andlauer Healthcare Group Inc

Andlauer Healthcare Group (AND) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Andlauer Healthcare Group Inc

Q2 2024 earnings summary

2 Feb, 2026

Executive summary

  • Q2 2024 revenue rose 2.6% year-over-year to $161.4 million, driven by organic growth in Canadian specialized transportation and recovery in logistics, distribution, and packaging.

  • Canadian specialized transportation network delivered strong organic growth, with all product lines posting year-over-year revenue increases in Q2 2024.

  • Healthcare logistics segment returned to growth in both logistics/distribution and packaging product lines.

  • U.S. truckload business faced continued revenue and margin declines due to persistent post-pandemic rate pressures, resulting in the lowest margins since market entry.

  • Strong cash generation and low debt enabled significant share buybacks, including a $90 million substantial issuer bid and ongoing normal course issuer bid.

Financial highlights

  • Healthcare logistics segment revenue was $44.2 million, up 1.3% year-over-year, with 13% growth in packaging revenue.

  • Specialized transportation segment revenue reached $117.2 million, a 3.1% increase year-over-year, driven by Canadian organic growth and partially offset by U.S. truckload decline.

  • Ground transportation revenue was $105 million, up 1.5% year-over-year; air freight forwarding revenue was $7.9 million, up 3.1%.

  • Operating income was $22.2 million, down 1.9% year-over-year, mainly due to lower U.S. truckload contributions and higher SG&A expenses.

  • Net income was $15.7 million ($0.38 per diluted share), flat versus Q2 2023; total comprehensive income increased 69.2% to $18.1 million due to positive foreign currency translation.

  • EBITDA totaled $40.1 million, up 1.4% year-over-year; EBITDA margin was 24.8%, slightly down from 25.1% last year.

Outlook and guidance

  • Management expects to leverage its platform and core competencies to drive shareholder value, supported by positive long-term industry growth fundamentals in healthcare, transportation, and logistics.

  • Focus remains on improving U.S. truckload operations and pursuing disciplined financial and operational metrics.

  • Management remains focused on revenue quality, especially in the U.S. truckload segment, and continues to evaluate complementary acquisitions.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more